COMPASS Pathways (CMPS)
NASDAQ: CMPS
· Real-Time Price · USD
5.54
0.50 (9.92%)
At close: Sep 24, 2025, 3:59 PM
5.55
0.18%
After-hours: Sep 24, 2025, 07:56 PM EDT
9.92% (1D)
| Bid | 5.54 |
| Market Cap | 518.47M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -138.56M |
| EPS (ttm) | -1.81 |
| PE Ratio (ttm) | -3.06 |
| Forward PE | -3.32 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.55 |
| Volume | 2,257,705 |
| Avg. Volume (20D) | 2,172,646 |
| Open | 5.10 |
| Previous Close | 5.04 |
| Day's Range | 5.07 - 5.55 |
| 52-Week Range | 2.25 - 7.08 |
| Beta | 2.18 |
| Ex-Dividend Date | n/a |
About CMPS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-0.65%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
2 months ago
+3.72%
Shares of psychedelic companies are trading higher following a report suggesting California Governor Newsom said he is "all in" on expanding access to psychedelics for therapeutic use.
4 weeks ago · businesswire.com
Compass Pathways to Participate in Four Investor Conferences in SeptemberLONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal...
1 month ago · fool.com
Compass (CMPS) Q2 Loss Improves 27%Compass (CMPS) Q2 Loss Improves 27%
2 months ago · businesswire.com
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal...